{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:30:22Z","timestamp":1770726622109,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ryan Translational Research Fund, Eastern Virginia Medical School."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to pose major health challenges despite effective vaccination efforts. The sustained occurrence of breakthrough infections and emerging variants of the virus highlights the need for additional therapeutic strategies. Given the anti-inflammatory role of the cannabinoid type 2 receptor (CB2R), we examined the effect of CB2R activation in SARS-CoV-2 spike protein subunit 1 (S1SP)-induced acute lung injury (ALI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ALI was induced in mice by intratracheal (i.t.) administration of S1SP, followed by treatment with the CB2R agonist HU308 (5 mg\/kg, intraperitoneal: i.p.) 1 h post-S1SP and every 24 h thereafter. Lung function, bronchoalveolar lavage fluid (BALF) parameters, cytokine levels, and inflammatory signaling were assessed at 48 h following S1SP exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HU308 treatment significantly reduced S1SP-induced pulmonary dysfunction, immune cell infiltration, neutrophil activation, and proinflammatory cytokine production, while suppressing NF-\u03baB and STAT3 activation. HU308 treatment restored the Nrf2 expression in the lung.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CB2R activation ameliorates S1SP-induced lung inflammation and injury, suggesting its therapeutic potential against COVID-19-related ALI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00408-026-00870-6","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T03:44:13Z","timestamp":1770608653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-CoV-2 Spike Protein\u2013Induced Acute Lung Injury in Mice"],"prefix":"10.1007","volume":"204","author":[{"given":"Janette","family":"Lockett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Washington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaraja","family":"Nagre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"870_CR1","unstructured":"(2025) COVID-19 Cases. World WHO COVID-19 dashboard. https:\/\/data.who.int\/dashboards\/covid19\/cases"},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1038\/s41586-020-2951-z","volume":"588","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G et al (2020) Addendum: a pneumonia outbreak associated with a new coronavirus of probable Bat origin. Nature 588:E6\u2013E6. https:\/\/doi.org\/10.1038\/s41586-020-2951-z","journal-title":"Nature"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180:934. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","volume":"39","author":"M Soy","year":"2020","unstructured":"Soy M, Keser G, Atag\u00fcnd\u00fcz P et al (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39:2085\u20132094. https:\/\/doi.org\/10.1007\/s10067-020-05190-5","journal-title":"Clin Rheumatol"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"e34577","DOI":"10.1016\/j.heliyon.2024.e34577","volume":"10","author":"J Zhang","year":"2024","unstructured":"Zhang J (2024) Immune responses in COVID-19 patients: insights into cytokine storms and adaptive immunity kinetics. Heliyon 10:e34577. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34577","journal-title":"Heliyon"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/jcm14082851","volume":"14","author":"P Simankowicz","year":"2025","unstructured":"Simankowicz P, St\u0119pniewska J (2025) The role of endocannabinoids in physiological processes and disease pathology: a comprehensive review. J Clin Med 14:2851. https:\/\/doi.org\/10.3390\/jcm14082851","journal-title":"J Clin Med"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"CJ Hillard","year":"2018","unstructured":"Hillard CJ (2018) Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacol 43:155\u2013172. https:\/\/doi.org\/10.1038\/npp.2017.130","journal-title":"Neuropsychopharmacol"},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/21505594.2017.1389369","volume":"9","author":"A Tahamtan","year":"2018","unstructured":"Tahamtan A, Samieipoor Y, Nayeri FS et al (2018) Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice. Virulence 9:217\u2013230. https:\/\/doi.org\/10.1080\/21505594.2017.1389369","journal-title":"Virulence"},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/01902148.2018.1543368","volume":"44","author":"E Wawryk-Gawda","year":"2018","unstructured":"Wawryk-Gawda E, Ch\u0142apek K, Zarobkiewicz MK et al (2018) CB2R agonist prevents nicotine induced lung fibrosis. Exp Lung Res 44:344\u2013351. https:\/\/doi.org\/10.1080\/01902148.2018.1543368","journal-title":"Exp Lung Res"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12931-022-02253-w","volume":"23","author":"N Nagre","year":"2022","unstructured":"Nagre N, Nicholson G, Cong X et al (2022) Activation of cannabinoid-2 receptor protects against Pseudomonas aeruginosa induced acute lung injury and inflammation. Respir Res 23:326. https:\/\/doi.org\/10.1186\/s12931-022-02253-w","journal-title":"Respir Res"},{"key":"870_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/ph18020236","volume":"18","author":"G Nicholson","year":"2025","unstructured":"Nicholson G, Richards N, Lockett J et al (2025) Cannabinoid-2 receptor activation attenuates sulfur mustard analog 2-Chloroethyl-Ethyl-Sulfide-Induced acute lung injury in mice. Pharmaceuticals 18:236. https:\/\/doi.org\/10.3390\/ph18020236","journal-title":"Pharmaceuticals"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"100022","DOI":"10.1124\/jpet.124.002154","volume":"392","author":"PA Solopov","year":"2025","unstructured":"Solopov PA, Colunga Biancatelli RML, Day T et al (2025) KVX-053, a protein tyrosine phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 Spike protein subunit 1\u2013induced acute lung injury in mice. J Pharmacol Exp Ther 392:100022. https:\/\/doi.org\/10.1124\/jpet.124.002154","journal-title":"J Pharmacol Exp Ther"},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12931-025-03143-7","volume":"26","author":"J Zhu","year":"2025","unstructured":"Zhu J, Wu J, Lu M et al (2025) Acute lung injury induced by Recombinant SARS-CoV-2 Spike protein subunit S1 in mice. Respir Res 26:59. https:\/\/doi.org\/10.1186\/s12931-025-03143-7","journal-title":"Respir Res"},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"L477","DOI":"10.1152\/ajplung.00223.2021","volume":"321","author":"RML Colunga Biancatelli","year":"2021","unstructured":"Colunga Biancatelli RML, Solopov PA, Sharlow ER et al (2021) The SARS-CoV-2 Spike protein subunit S1 induces COVID-19-like acute lung injury in \u019818-hACE2 Transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol 321:L477\u2013L484. https:\/\/doi.org\/10.1152\/ajplung.00223.2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"870_CR15","doi-asserted-by":"publisher","unstructured":"Cui H, Jiang D, Banerjee S, Xie N, Kulkarni T, Liu R-M, Duncan SR, Liu G (2020) Monocyte-derived alveolar macrophage Apolipoprotein E participates in pulmonary fibrosis resolution. JCI Insight 5(5). https:\/\/doi.org\/10.1172\/jci.insight.134539","DOI":"10.1172\/jci.insight.134539"},{"issue":"5","key":"870_CR16","doi-asserted-by":"publisher","first-page":"L452","DOI":"10.1152\/ajplung.00089.2015","volume":"310","author":"N Nagre","year":"2016","unstructured":"Nagre N, Wang S, Kellett T, Kanagasabai R, Deng J, Nishi M, Shilo K, Oeckler RA, Yalowich JC, Takeshima H, Christman J, Hubmayr RD, Zhao X (2016) TRIM72 modulates caveolar endocytosis in repair of lung cells. Am J Physiol Lung Cell Mol Physiol 310(5):L452\u2013L464. https:\/\/doi.org\/10.1152\/ajplung.00089.2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"870_CR17","doi-asserted-by":"publisher","first-page":"1170012","DOI":"10.3389\/fimmu.2023.1170012","volume":"14","author":"HC Hawerkamp","year":"2023","unstructured":"Hawerkamp HC, Dyer AH, Patil ND et al (2023) Characterisation of the pro-inflammatory cytokine signature in severe COVID-19. Front Immunol 14:1170012. https:\/\/doi.org\/10.3389\/fimmu.2023.1170012","journal-title":"Front Immunol"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"809952","DOI":"10.3389\/fcell.2021.809952","volume":"9","author":"W Gao","year":"2022","unstructured":"Gao W, Guo L, Yang Y, Wang Y, Xia S, Gong H, Zhang BK, Yan M (2022) Dissecting the crosstalk between Nrf2 and NF-\u03baB response pathways in drug-induced toxicity. Front Cell Dev Biol 9:809952. https:\/\/doi.org\/10.3389\/fcell.2021.809952","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"870_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans 43(4):621\u2013626. https:\/\/doi.org\/10.1042\/BST20150014","journal-title":"Biochem Soc Trans"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lfs.2019.05.056","volume":"230","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhang M, Wang L, Yu T, Jiang S, Jiang P, Sun Y, Pi J, Zhao R, Guan D (2019) Activation of cannabinoid type 2 receptor protects skeletal muscle from ischemia-reperfusion injury partly via Nrf2 signaling. Life Sci 230:55\u201367. https:\/\/doi.org\/10.1016\/j.lfs.2019.05.056","journal-title":"Life Sci"},{"key":"870_CR21","doi-asserted-by":"publisher","unstructured":"Li X, Han D, Tian Z, Gao B, Fan M, Li C, Li X, Wang Y, Ma S, Cao F (2016) Activation of cannabinoid receptor type II by AM1241 ameliorates myocardial fibrosis via Nrf2-mediated inhibition of TGF-\u03b21\/Smad3 pathway in myocardial infarction mice. Cell Physiol Biochem. 2016;39(4):1521-36. https:\/\/doi.org\/10.1159\/000447855","DOI":"10.1159\/000447855"},{"key":"870_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Yalavarthi S, Shi H et al (2020) Neutrophil extracellular traps in COVID-19. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.138999","journal-title":"JCI Insight"},{"issue":"2","key":"870_CR23","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.4110\/in.2021.21.e16","volume":"21","author":"Y-J Youn","year":"2021","unstructured":"Youn Y-J, Lee Y-B, Kim S-H et al (2021) Nucleocapsid and Spike proteins of SARS-CoV-2 drive neutrophil extracellular trap formation. Immune Netw 21(2):e16. https:\/\/doi.org\/10.4110\/in.2021.21.e16","journal-title":"Immune Netw"},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41423-022-00845-6","volume":"19","author":"W Hong","year":"2022","unstructured":"Hong W, Yang J, Zou J et al (2022) Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the Spike protein subunit 2 and Sialic acid on host cells. Cell Mol Immunol 19:577\u2013587. https:\/\/doi.org\/10.1038\/s41423-022-00845-6","journal-title":"Cell Mol Immunol"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fimmu.2012.00360","volume":"3","author":"AS Rohrbach","year":"2012","unstructured":"Rohrbach AS, Slade DJ, Thompson PR et al (2012) Activation of PAD4 in NET formation. Front Immunol 3:360. https:\/\/doi.org\/10.3389\/fimmu.2012.00360","journal-title":"Front Immunol"},{"key":"870_CR26","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.3390\/molecules29143381","volume":"29","author":"V Rakotoarivelo","year":"2024","unstructured":"Rakotoarivelo V, Mayer TZ, Simard M et al (2024) The impact of the CB2 cannabinoid receptor in inflammatory diseases: an update. Molecules 29:3381. https:\/\/doi.org\/10.3390\/molecules29143381","journal-title":"Molecules"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00870-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:04:58Z","timestamp":1770653098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00870-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00870-6","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"7"}}